Diamyd Medical (Sweden) Price on July 23, 2024
| DMYD-B Stock | SEK 15.44 0.46 2.89% |
If you're considering investing in Diamyd Stock, it is important to understand the factors that can impact its price. As of today, the current price of Diamyd Medical stands at 15.44, as last reported on the 11th of December 2024, with the highest price reaching 16.30 and the lowest price hitting 15.10 during the day. At this point, Diamyd Medical is not too volatile. Diamyd Medical AB secures Sharpe Ratio (or Efficiency) of 0.0493, which denotes the company had a 0.0493% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Diamyd Medical AB, which you can use to evaluate the volatility of the firm. Please confirm Diamyd Medical's Mean Deviation of 2.12, downside deviation of 2.25, and Semi Deviation of 2.07 to check if the risk estimate we provide is consistent with the expected return of 0.14%.
Diamyd Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Diamyd |
Sharpe Ratio = 0.0493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | DMYD-B | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.81 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Diamyd Medical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Diamyd Medical by adding it to a well-diversified portfolio.
Diamyd Medical Valuation on July 23, 2024
It is possible to determine the worth of Diamyd Medical on a given historical date. On July 23, 2024 Diamyd was worth 15.5 at the beginning of the trading date compared to the closed value of 18.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Diamyd Medical stock. Still, in general, we apply an absolute valuation method to find Diamyd Medical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Diamyd Medical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Diamyd Medical's related companies.
| Open | High | Low | Close | Volume | |
| 13.32 | 14.18 | 13.08 | 14.16 | 142,826 | |
07/23/2024 | 15.50 | 18.50 | 15.04 | 18.30 | 2,206,116 |
| 18.00 | 19.24 | 17.66 | 18.50 | 868,351 |
| Backtest Diamyd Medical | | | Diamyd Medical History | | | Diamyd Medical Valuation | Previous | Next |
Diamyd Medical Trading Date Momentum on July 23, 2024
| On July 24 2024 Diamyd Medical AB was traded for 18.50 at the closing time. The highest price during the trading period was 19.24 and the lowest recorded bid was listed for 17.66 . The volume for the day was 868.4 K. This history from July 24, 2024 contributed to the next trading day price jump. The overall trading delta to the next closing price was 1.09% . The overall trading delta to the current price is 1.75% . |
Diamyd Medical AB Fundamentals Correlations and Trends
By evaluating Diamyd Medical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Diamyd Medical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Diamyd financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Diamyd Medical Stock history
Diamyd Medical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Diamyd is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Diamyd Medical AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Diamyd Medical stock prices may prove useful in developing a viable investing in Diamyd Medical
Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.
Diamyd Medical Stock Technical Analysis
Diamyd Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Diamyd Medical Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Diamyd Medical AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Diamyd Medical December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Diamyd Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Diamyd Medical shares will generate the highest return on investment. By undertsting and applying Diamyd Medical stock market strength indicators, traders can identify Diamyd Medical AB entry and exit signals to maximize returns
Diamyd Medical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Diamyd Medical's price direction in advance. Along with the technical and fundamental analysis of Diamyd Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Diamyd to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0456 | |||
| Jensen Alpha | 0.0391 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0106 | |||
| Treynor Ratio | 0.1595 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |